A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data.
Saved in:
| Title: | A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data. |
|---|---|
| Authors: | Gatto NM; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Kaiser Permanente, Bernard Tyson School of Medicine, Pasadena, California, USA., Cronkite DJ; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA., Wartko PD; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Ball R; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Carrell DS; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA., Eniafe R; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Desai R; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Floyd JS; Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington, USA., Lee T; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Nelson JC; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA., Shebl FM; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Schoeplein R; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA., Toh S; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA., Zhang M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Dublin S; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Kaiser Permanente, Bernard Tyson School of Medicine, Pasadena, California, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Hernández-Muñoz JJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA. |
| Source: | Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2026 Mar; Vol. 35 (3), pp. e70346. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
